van der Burgt YEM - Search Results

1

Serum N-Glycome analysis reveals pancreatic cancer disease signatures.

Vreeker GCM, Hanna-Sawires RG, Mohammed Y, Bladergroen MR, Nicolardi S, Dotz V, Nouta J, Bonsing BA, Mesker WE, van der Burgt YEM, Wuhrer M, Tollenaar RAEM. Vreeker GCM, et al. Among authors: van der burgt yem. Cancer Med. 2020 Nov;9(22):8519-8529. doi: 10.1002/cam4.3439. Epub 2020 Sep 8. Cancer Med. 2020. PMID: 32898301 Free PMC article.

2

Quality control based on isotopic distributions for high-throughput MALDI-TOF and MALDI-FTICR serum peptide profiling.

Nicolardi S, Palmblad M, Dalebout H, Bladergroen M, Tollenaar RA, Deelder AM, van der Burgt YE. Nicolardi S, et al. J Am Soc Mass Spectrom. 2010 Sep;21(9):1515-25. doi: 10.1016/j.jasms.2010.05.004. Epub 2010 May 12. J Am Soc Mass Spectrom. 2010. PMID: 20541438 Free article.

3

Proteomic serum biomarkers and their potential application in cancer screening programs.

Huijbers A, Velstra B, Dekker TJ, Mesker WE, van der Burgt YE, Mertens BJ, Deelder AM, Tollenaar RA. Huijbers A, et al. Int J Mol Sci. 2010 Oct 26;11(11):4175-93. doi: 10.3390/ijms11114175. Int J Mol Sci. 2010. PMID: 21151433 Free PMC article. Review.

4

Mass spectrometric glycan rearrangements.

Wuhrer M, Deelder AM, van der Burgt YE. Wuhrer M, et al. Mass Spectrom Rev. 2011 Jul-Aug;30(4):664-80. doi: 10.1002/mas.20337. Epub 2011 May 10. Mass Spectrom Rev. 2011. PMID: 21560141 Review.

5

Precision profiling and identification of human serum peptides using Fourier transform ion cyclotron resonance mass spectrometry.

Nicolardi S, Palmblad M, Hensbergen PJ, Tollenaar RA, Deelder AM, van der Burgt YE. Nicolardi S, et al. Rapid Commun Mass Spectrom. 2011 Dec 15;25(23):3457-63. doi: 10.1002/rcm.5246. Rapid Commun Mass Spectrom. 2011. PMID: 22095492

6

Top-down FTICR MS for the identification of fluorescent labeling efficiency and specificity of the Cu-protein azurin.

Nicolardi S, Andreoni A, Tabares LC, van der Burgt YE, Canters GW, Deelder AM, Hensbergen PJ. Nicolardi S, et al. Anal Chem. 2012 Mar 6;84(5):2512-20. doi: 10.1021/ac203370f. Epub 2012 Feb 23. Anal Chem. 2012. PMID: 22320330

7

Identification of human serum peptides in fourier transform ion cyclotron resonance precision profiles.

Nicolardi S, Dalebout H, Bladergroen MR, Mesker WE, Tollenaar RA, Deelder AM, van der Burgt YE. Nicolardi S, et al. Int J Proteomics. 2012;2012:804036. doi: 10.1155/2012/804036. Epub 2012 May 22. Int J Proteomics. 2012. PMID: 22685657 Free PMC article.

8

Improved classification of breast cancer peptide and protein profiles by combining two serum workup procedures.

Velstra B, van der Burgt YE, Mertens BJ, Mesker WE, Deelder AM, Tollenaar RA. Velstra B, et al. J Cancer Res Clin Oncol. 2012 Dec;138(12):1983-92. doi: 10.1007/s00432-012-1273-4. Epub 2012 Jul 5. J Cancer Res Clin Oncol. 2012. PMID: 22763645 Free PMC article.

9

Standardized and automated solid-phase extraction procedures for high-throughput proteomics of body fluids.

Bladergroen MR, Derks RJ, Nicolardi S, de Visser B, van Berloo S, van der Burgt YE, Deelder AM. Bladergroen MR, et al. J Proteomics. 2012 Dec 21;77:144-53. doi: 10.1016/j.jprot.2012.07.023. Epub 2012 Jul 26. J Proteomics. 2012. PMID: 22842157

10

Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors.

Gianazza E, Chinello C, Mainini V, Cazzaniga M, Squeo V, Albo G, Signorini S, Di Pierro SS, Ferrero S, Nicolardi S, van der Burgt YE, Deelder AM, Magni F. Gianazza E, et al. J Proteomics. 2012 Dec 5;76 Spec No.:125-40. doi: 10.1016/j.jprot.2012.07.032. Epub 2012 Jul 31. J Proteomics. 2012. PMID: 22868251 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page